Quick Stats for Obesity GLP-1 Market Obesity GLP-1 Market Value (2025): USD 8,169 million Obesity GLP-1 Market Forecast Value (2035): USD 65,364 million Obesity GLP-1 Market Forecast CAGR: 23.1% Leading Molecule Class in Obesity GLP-1 Market: Semaglutide (58.0%) Key Growth Regions in Obesity GLP-1 Market: North America, Europe, and East Asia Top Key Players in Obesity GLP-1 Market: Novo Nordisk, Eli Lilly, and emerging manufacturers Between 2025 and 2030, the obesity GLP-1 market is projected to expand from USD 8169.0 million to USD 39,528 million, resulting in a value increase of USD 31359.0 million, which represents 54.8% of the total forecast growth for the decade
L-Glutathione Glutathione is the master antioxidant in the body and is heavily concentrated in tissues such as the liver, spleen and heart
How 5-Amino-1MQ works NNMT methylates nicotinamide, diverting it away from NAD+ production and burning through SAM in the process
Metabolism and Weight Management Supplement
Studies have also shown that drinking yerba mate tea can naturally improve serum lipid levels, thereby lowering cholesterol levels